Environmental Mastitis

Environmental mastitis encompasses intramammary infections caused by bacteria that originate from the cow's surroundings rather than from other infected cows. These pathogens are ubiquitous in the dairy environment, living in bedding materials, manure, soil, water, and on skin surfaces. Unlike contagious mastitis pathogens that reside primarily in infected udders and spread during milking, environmental organisms infect the mammary gland between milkings when teats contact contaminated surfaces in housing areas, holding pens, and pastures. This fundamental difference in transmission epidemiology requires distinct prevention strategies focused on environmental hygiene and cow immune status rather than solely on milking-time interventions.

The principal environmental mastitis pathogens fall into two major groups with different clinical presentations and management implications. Environmental streptococci, particularly Streptococcus uberis along with Streptococcus dysgalactiae and enterococci, typically cause mild to moderate clinical mastitis and may establish chronic subclinical infections. Coliform bacteria, including Escherichia coli, Klebsiella species, and Enterobacter species, more commonly cause acute severe clinical disease with potential for systemic toxemia. Other environmental pathogens including Pseudomonas aeruginosa, Serratia marcescens, and various yeast and fungal organisms cause occasional problems, often associated with specific environmental contamination sources or treatment-related introduction.

Environmental mastitis has become the predominant form of mastitis in well-managed dairy herds that have successfully controlled contagious pathogens through post-milking teat disinfection, dry cow therapy, and culling programs. As bulk tank somatic cell counts have declined with contagious mastitis control, environmental infections now account for the majority of clinical mastitis cases and an increasing proportion of elevated cell counts in leading herds. The shift toward environmental pathogen dominance has occurred alongside changes in dairy housing, with intensification of indoor management and use of various bedding materials influencing pathogen exposure. Understanding environmental mastitis epidemiology is essential for continued progress in udder health.

Prevention and control of environmental mastitis require comprehensive approaches addressing multiple risk factors. Environmental hygiene including stall maintenance, bedding management, and alley cleanliness reduces bacterial exposure. Cow immunity optimization through nutrition, vaccination, and stress reduction enhances resistance to infection. Teat condition maintenance through proper milking practices and barrier teat dips protects the physical defenses against bacterial invasion. Treatment protocols for clinical cases and appropriate dry cow management address infections when they occur. Success requires sustained attention to multiple management areas rather than single interventions.

Environmental streptococci constitute a major group of environmental mastitis pathogens, with Streptococcus uberis being the most common and clinically significant member. This organism has adapted remarkably well to the bovine environment, surviving in bedding, soil, and on various body surfaces including the skin, lips, and rumen. Unlike the obligate mammary pathogen Streptococcus agalactiae, S. uberis can multiply in organic bedding materials and persist in the environment for extended periods. Streptococcus dysgalactiae shares some environmental reservoirs but also colonizes teat skin, giving it characteristics intermediate between purely environmental and contagious pathogens. Enterococci and other environmental streptococci cause occasional mastitis of generally lower clinical severity.

Coliform bacteria represent the other major group of environmental mastitis pathogens, causing infections that tend to be more acute and severe than streptococcal cases. Escherichia coli is the most commonly isolated coliform, normally inhabiting the bovine intestinal tract and abundantly contaminating manure and manure-soiled environments. Klebsiella species, particularly Klebsiella pneumoniae and Klebsiella oxytoca, are associated with organic bedding materials, especially sawdust and recycled manure solids, where they multiply to very high numbers. Enterobacter species occasionally cause mastitis with clinical presentation similar to other coliforms. The endotoxin produced by all gram-negative bacteria drives the severe systemic illness seen in toxic coliform mastitis.

Environmental and management factors directly determine environmental mastitis incidence by influencing both bacterial exposure and cow susceptibility. Bedding material choice profoundly affects bacterial populations, with organic materials including sawdust, straw, and recycled manure supporting higher pathogen numbers than inorganic options like sand. Bedding moisture content correlates with bacterial multiplication, making water management critical. Stall design and maintenance affect how much time cows spend lying in contaminated bedding versus on clean surfaces. Stocking density impacts both environmental contamination levels and stress-related immune suppression. Holding pen time and conditions, alley cleanliness, and water source hygiene all contribute to overall exposure.

Risk factors for environmental mastitis relate to both management conditions and individual cow characteristics. The periparturient period presents the highest risk time due to immune suppression associated with calving, negative energy balance, and the vulnerability of early lactation. High-producing cows may have increased susceptibility due to immune demands of heavy production. Teat end condition, particularly hyperkeratosis, affects bacterial entry opportunity. Previous mastitis episodes may damage teat defenses. Housing and weather conditions influence both environmental contamination and cow stress. Season affects pathogen populations, with warm humid conditions favoring bacterial growth. Concurrent diseases and metabolic disorders compromise immune function.

The pathophysiology of environmental mastitis differs between streptococcal and coliform infections. Environmental streptococci typically cause infection characterized by chronic colonization of milk ducts and cistern with ongoing low-grade inflammation and intermittent clinical flares. Cure rates with antibiotic treatment are moderate, and reinfection from environmental sources is common. Coliform infections more typically cause acute severe inflammation with rapid bacterial multiplication followed by immune-mediated clearance within twenty-four to forty-eight hours. The endotoxin released during bacterial death causes systemic inflammatory response, and disease severity correlates more with the intensity of inflammation than with bacterial numbers. This explains why supportive care targeting endotoxemia may be more important than antibiotic therapy in coliform mastitis.

Early warning signs of environmental mastitis may be subtle and vary based on the causative pathogen. Streptococcal infections often begin with modest changes in milk appearance including slight wateriness, small flakes, or minor discoloration that may be detected during foremilk stripping. Mild swelling or firmness of the affected quarter may be palpable before dramatic clinical signs develop. Small decreases in production from individual quarters may precede obvious illness. Behavioral changes are often minimal in early streptococcal disease. Coliform mastitis may present more suddenly with rapid progression from normal to severely ill within hours. Any acute change in cow behavior or attitude warrants careful udder evaluation.

Clinical symptoms of environmental mastitis present along a spectrum from mild to severe. Mild cases show abnormal milk with flakes, clots, or discoloration, mild quarter swelling and firmness, and minimal systemic signs. The cow remains essentially normal in behavior and appetite with slight fever or normal temperature. Moderate cases present with obvious quarter swelling, heat, and pain along with clearly abnormal watery or clotted milk. Systemic signs include fever, reduced appetite, and mild depression. Severe cases, most common with coliform infections, show marked systemic illness with high fever or hypothermia, profound depression, complete anorexia, and evidence of dehydration and shock. The affected quarter may become cold and discolored.

Behavioral changes provide important indicators of environmental mastitis severity. Reduced feed intake progresses from slight in mild cases to complete anorexia in severe disease. Rumination decreases proportionally to illness severity. Cows may isolate from herdmates, seek shade or protection, and show reluctance to move. Milk let-down is impaired in painful quarters, with cows showing discomfort during milking. Lying behavior changes, with affected animals either avoiding lying on painful quarters or becoming recumbent due to weakness. Activity monitoring systems may detect reduced movement and altered rest patterns. Recognition of these behavioral indicators allows earlier detection than relying solely on visual udder changes.

Physical examination reveals findings corresponding to infection type and severity. Quarter assessment detects swelling ranging from slight in mild streptococcal cases to dramatic in severe coliform mastitis. Heat and pain on palpation are proportional to inflammation intensity. Milk from affected quarters shows abnormalities ranging from minor flakes to watery serum-like secretions or bloody discharge. Systemic parameters including temperature, heart rate, respiratory rate, and hydration status indicate disease severity. Rectal temperature may exceed 105 degrees Fahrenheit in acute cases or fall below normal in advanced shock. Rumen motility assessment and mucous membrane evaluation complete the systemic evaluation.

Symptom progression follows different patterns depending on the causative pathogen. Streptococcal environmental mastitis typically shows gradual onset with fluctuating clinical severity over days to weeks. Spontaneous improvement may occur followed by recurrence. Chronic subclinical infection may develop with persistently elevated cell counts. Coliform mastitis progresses rapidly, with severe systemic illness developing within twelve to twenty-four hours of onset. Without treatment, severe coliform mastitis may result in death within twenty-four to forty-eight hours in the most acute cases. Surviving animals may show gradual improvement over several days with appropriate supportive care. Some coliform infections present as mild self-limiting clinical episodes.

Emergency symptoms requiring immediate veterinary intervention include signs of severe endotoxemia and shock. Recumbency or inability to rise indicates life-threatening illness. Cold extremities with pale or cyanotic mucous membranes suggest cardiovascular collapse. Temperature below normal in a previously febrile cow indicates deteriorating condition. Bloody or foul-smelling secretions from the affected quarter warrant urgent evaluation. Rapid enlargement with cold, discolored tissue suggests gangrenous change. Complete cessation of milk production from all quarters indicates severe systemic illness. Any cow with mastitis showing rapid deterioration despite initial treatment requires reassessment and intensified therapy.

Clinical examination for environmental mastitis follows systematic protocols for comprehensive mammary and systemic assessment. All four quarters require evaluation regardless of which quarters show obvious abnormality, as multiple quarter infections and subclinical involvement of additional quarters are common. Visual inspection assesses symmetry, swelling, and skin color. Palpation evaluates heat, firmness, and pain response. Foremilk from each quarter is stripped onto a dark surface for visual assessment and subjected to California Mastitis Test for inflammation estimation. Systemic examination including temperature, heart rate, respiratory rate, hydration status, and mucous membrane color guides treatment intensity decisions. Thorough examination ensures accurate severity classification.

Diagnostic testing provides essential pathogen identification for appropriate treatment and epidemiologic understanding. Milk samples should be collected aseptically from affected quarters before antibiotic administration for the most accurate culture results. Standard aerobic culture on blood agar and selective media differentiates between major pathogen groups within twenty-four to forty-eight hours. Identification to species level guides treatment selection and helps identify environmental sources. Antimicrobial susceptibility testing informs drug choice, particularly for streptococcal infections where treatment response is more variable. On-farm culture systems allow rapid differentiation of gram-positive versus gram-negative organisms, enabling protocol-based treatment initiation while awaiting complete laboratory results.

Differential diagnosis of clinical mastitis includes distinguishing between environmental pathogens and other mastitis causes. Contagious pathogens including Staphylococcus aureus and Streptococcus agalactiae cause similar clinical presentations but have different epidemiologic implications and control requirements. Culture is essential for accurate differentiation. Summer mastitis with its characteristic mixed anaerobic flora presents distinctively with foul-smelling discharge. Mycoplasma mastitis, an important contagious pathogen, requires special culture media for detection and should be considered in outbreak situations. Non-infectious conditions including udder edema and trauma may initially appear similar. Systemic diseases causing fever and depression require udder examination to rule out mastitis as the cause.

Herd-level diagnostic evaluation helps characterize environmental mastitis patterns and identify management risk factors. Bulk tank culture provides limited information for environmental pathogens since they cause sporadic rather than widespread infections. Individual cow culture surveys establish pathogen distribution within the herd. Analysis of clinical mastitis records including timing, severity, and pathogen identification reveals patterns suggesting specific risk factors. New infection rates during the dry period versus lactation indicate relative importance of different management areas. Environmental sampling of bedding materials quantifies bacterial loads and may identify specific contamination sources. Water culture may reveal Pseudomonas or other waterborne organisms when unusual pathogens are isolated.

Treatment of environmental streptococcal mastitis relies primarily on intramammary antibiotic therapy, with systemic treatment reserved for more severe cases. Most environmental streptococci including Streptococcus uberis show susceptibility to commonly used intramammary antibiotics including beta-lactams, though treatment response is variable and cure rates are often modest. Standard labeled intramammary therapy administered according to product directions provides the foundation of treatment. Extended therapy protocols using additional days of treatment may improve cure rates for S. uberis, which tends to cause chronic infections. Combination of intramammary and systemic therapy may be considered for moderate to severe cases. Anti-inflammatory therapy helps manage clinical signs and may improve cure rates.

Coliform mastitis treatment emphasizes supportive care targeting endotoxemia rather than focusing solely on antimicrobial therapy. The rationale is that most coliform infections are rapidly cleared by the immune response, and the bacteria are often eliminated before antibiotic therapy has full effect. The severe clinical signs result from endotoxin release rather than bacterial presence. Aggressive intravenous fluid therapy combats dehydration and supports circulation. Non-steroidal anti-inflammatory drugs including flunixin meglumine counteract endotoxin effects and provide pain relief. Frequent stripping of the affected quarter removes toxins and inflammatory mediators. Systemic antibiotics are commonly administered despite limited evidence for efficacy, with broad-spectrum drugs covering gram-negative organisms being appropriate choices.

Severe environmental mastitis cases require intensive emergency care to prevent mortality. Intravenous fluid therapy using hypertonic saline followed by large volumes of isotonic fluids addresses the profound dehydration and circulatory compromise of endotoxic shock. Administration may require indwelling intravenous catheters for continued access. Anti-inflammatory therapy should be initiated early and may be repeated according to labeled intervals. Calcium supplementation supports muscle function and immune response, particularly in periparturient cows at risk for hypocalcemia. Nursing care including deep bedding, assistance rising, and temperature regulation supports recovery. Round-the-clock monitoring and treatment may be necessary for the first twenty-four to forty-eight hours.

Supportive care complements specific antimicrobial and anti-inflammatory treatment. Oral fluid and electrolyte therapy supplements intravenous treatment once the cow can swallow safely. Energy supplementation with propylene glycol or oral glucose addresses the negative energy balance of anorexia. Rumen function may be supported with transfaunation if stasis is prolonged. Pain management through continued NSAID administration improves animal welfare and may enhance recovery. Appetite stimulation with palatable feeds encourages return to normal intake. Shelter from extreme temperatures and comfortable resting surfaces reduce stress and energy demands.

Herd treatment protocols should differentiate mild, moderate, and severe environmental mastitis presentations. Mild cases with minimal systemic signs may be managed with intramammary therapy alone following on-farm culture to guide drug selection. Moderate cases warrant combined intramammary and systemic antimicrobials along with anti-inflammatory therapy. Severe cases require aggressive supportive care in addition to antimicrobial and anti-inflammatory treatment. Protocols should specify when veterinary involvement is required and define criteria for treatment failure requiring reassessment. Record keeping documents treatments administered, withdrawal periods, and outcomes for program evaluation.

Treatment decisions balance medical considerations with economic realities of dairy production. Mild environmental mastitis cases generally warrant treatment given reasonable cure rates and modest costs. Severe coliform mastitis in valuable cows justifies intensive and expensive supportive care. Chronic non-responsive cases require assessment of continued treatment versus culling based on individual cow economics. Factors including production level, genetic value, stage of lactation, and number of functional quarters influence decisions. Quarter loss from severe mastitis may be compatible with continued production on three quarters in valuable genetics. Veterinary consultation helps optimize complex treatment decisions.

Recovery timeline for environmental mastitis varies substantially based on pathogen and disease severity. Mild environmental streptococcal mastitis may show improvement within two to three days of initiating treatment, with milk returning to normal appearance over one to two weeks. However, bacteriological cure may not be achieved, resulting in chronic subclinical infection with elevated cell counts. Coliform mastitis that does not progress to severe toxemia often resolves within several days as the immune response clears bacteria. Severe toxic coliform mastitis requires days to weeks for full recovery even when the acute crisis is successfully managed. Return to normal milk production from affected quarters may take weeks.

Post-treatment care and monitoring continues beyond resolution of acute clinical signs. Treated quarters should be monitored for recurrence of abnormal milk or swelling. California Mastitis Test or individual quarter somatic cell counts track inflammatory resolution. Culture of milk samples at appropriate intervals after completing treatment confirms bacteriological cure. Streptococcus uberis is particularly prone to treatment failure with apparent clinical cure but persistent infection. Ongoing monitoring through DHIA somatic cell count testing identifies chronically infected quarters. Cows recovering from severe systemic illness require continued supportive care and gradual return to normal management.

Prognosis factors for environmental mastitis include pathogen identity, severity, and treatment promptness. Streptococcus uberis infections carry moderate prognosis, with cure rates often ranging from sixty to seventy-five percent depending on chronicity and treatment protocol. Reinfection from environmental sources is common even following successful cure. Coliform infections typically either resolve with immune clearance or progress to severe disease, with intermediate outcomes less common. Severity at presentation strongly predicts outcome, with cows showing severe endotoxemia having guarded prognosis despite aggressive treatment. Early intervention before severe toxemia develops dramatically improves survival.

Return to production following environmental mastitis depends on the extent of mammary damage. Successfully treated streptococcal infections allow return to normal production from the affected quarter, though some loss may persist throughout the lactation. Coliform mastitis often causes more significant tissue damage, with affected quarters showing reduced production even after clinical cure. Severe cases may result in complete loss of quarter function. Assessing quarter damage through palpation and production monitoring guides expectations. Cows continuing with damaged or non-functional quarters must be evaluated for continued productivity and welfare. Total milk production depends on functional quarters remaining.

Vaccination provides partial protection against environmental mastitis pathogens, particularly coliforms. The E. coli J5 vaccine based on a rough mutant strain elicits antibodies that reduce clinical severity of coliform mastitis rather than preventing infection. Vaccination protocols typically involve a series of doses during the dry period and early lactation. Evidence supports reduced mortality, clinical severity, and production losses in vaccinated herds. Streptococcus uberis vaccines have been less successful in field conditions despite promising research results. Vaccination complements but does not replace environmental management and hygiene programs. Cost-benefit analysis generally favors vaccination in herds with significant coliform mastitis problems.

Environmental hygiene represents the foundation of environmental mastitis prevention. Bedding management profoundly affects bacterial exposure, with material choice, quantity, moisture control, and replacement frequency all influencing pathogen populations. Sand bedding supports lower bacterial counts than organic materials and is recommended where feasible. When organic bedding is used, fresh material must be added frequently and moisture managed carefully. Stall cleaning at least twice daily removes soiled bedding and manure. Alley scraping and drainage prevent accumulation of contaminated slurry. Holding pen management including stocking density, flooring surface, and cleanliness affects pre-milking teat contamination.

Milking hygiene practices reduce bacterial transfer to teats during milking. Effective pre-milking teat cleaning removes environmental contamination before unit attachment. Drying teats after washing prevents residual moisture from carrying bacteria into teat ends. Post-milking teat disinfection with effective germicidal barrier products provides both immediate bacterial kill and persistent protection until the teat canal closes. Milking equipment maintenance ensures proper function without vacuum fluctuations or liner slips that impact bacteria onto teat ends. Milking order has limited importance for environmental pathogens compared to contagious organisms.

Nutritional management supports immune function and environmental mastitis resistance. Adequate vitamin E and selenium enhance neutrophil function critical for mammary defense. Vitamin A and beta-carotene may provide additional immune support. Avoiding severe negative energy balance through appropriate transition cow nutrition maintains immune competence during the high-risk periparturient period. Adequate dietary protein supports antibody production and tissue integrity. Mycotoxin contamination impairs immune function and should be monitored and managed. Proper body condition through the dry period and early lactation indicates successful nutritional management.

Dry cow management profoundly influences environmental mastitis during the dry period and early lactation. Dry cow therapy, whether blanket or selective, addresses existing infections and provides early dry period protection. Internal teat sealants dramatically reduce new infections during the dry period by physically blocking the teat canal. Dry cow housing should be clean and dry with adequate space and ventilation. Maternity area hygiene is particularly important given the vulnerability around calving. Nutrition supporting immune function and proper calving condition reduces periparturient susceptibility. Fresh cow monitoring identifies early clinical cases for prompt treatment.

Daily management for environmental mastitis prevention requires consistent attention to multiple areas. Morning and evening stall maintenance adds fresh bedding and removes soiled material. Alley cleaning maintains walkways free of manure accumulation. Water availability and cleanliness are verified. Feed delivery ensures adequate and fresh intake to support immune function. Cow movement and behavior are observed for early illness detection. Milking procedures follow established protocols consistently. Environmental conditions including temperature and humidity are monitored, with adjustments to ventilation and cooling as needed. Documentation of any management issues supports continuous improvement.

Housing design and management directly impact environmental pathogen exposure. Stall dimensions appropriate for cow size promote proper lying position with minimal contact between udder and contaminated surfaces. Stall base and bedding selection consider both bacterial growth and cow comfort. Adequate space allowance prevents overcrowding that increases stress and environmental contamination. Ventilation systems maintain air quality and control moisture that promotes bacterial growth. Natural light and dry conditions discourage pathogen proliferation. Holding pen design minimizes time and stress before milking. Sick cow and maternity areas receive enhanced attention to cleanliness.

Herd health programs should systematically address environmental mastitis within comprehensive health management. Regular monitoring of mastitis records identifies trends in incidence, pathogen distribution, and treatment outcomes. Periodic culture surveys characterize herd pathogen profiles and guide intervention priorities. Bulk tank somatic cell count monitoring provides early warning of increasing problems. Dry cow protocols are reviewed and updated based on outcomes. Vaccination programs maintain current protection. Nutritional programs are evaluated for immune function support. Regular veterinary consultation provides objective assessment and recommendations.

Record systems support environmental mastitis monitoring and management decisions. Clinical mastitis records capture date, affected quarter, clinical severity, pathogen if cultured, treatment administered, and outcome. Monthly DHIA data provides individual cow somatic cell counts for subclinical monitoring. Bulk tank component and cell count history tracks herd trends. Treatment logs ensure withdrawal compliance. Environmental monitoring data including bedding bacteria counts and housing conditions identifies risk factors. Analysis of these records guides management changes and documents improvement.

Economic considerations influence environmental mastitis management investments and decisions. Prevention costs include bedding choice, labor for stall maintenance, vaccination, and dry cow products. Treatment expenses include drug costs, discarded milk, labor, and veterinary fees. Production losses from clinical and subclinical disease accumulate throughout lactation. Premature culling eliminates future production and requires replacement. Cost-benefit analysis helps prioritize investments in high-impact prevention strategies. Benchmarking against industry standards and peer operations identifies improvement opportunities. Return on investment from environmental improvements often exceeds returns from other farm investments.

All dairy cattle breeds are susceptible to environmental mastitis, with management factors generally more important than breed genetics in determining incidence. Holstein cattle account for the majority of cases due to their population dominance in commercial dairying worldwide. High production levels in Holsteins may increase vulnerability through greater immune suppression during early lactation and larger udders presenting more surface area for environmental contact. Some studies suggest slightly lower mastitis rates in Jersey cattle, potentially related to smaller udder size and lower production volume. Brown Swiss, Guernsey, Ayrshire, and other dairy breeds show variable susceptibility patterns without consistent trends across studies.

Production system and intensity influence environmental mastitis risk independently of breed. Intensive confinement housing typically presents greater environmental pathogen exposure than pasture-based systems, though the relationship depends on specific management in each system. High-producing cows experience greater negative energy balance and immune suppression during peak lactation. Cows in robotic milking systems face different exposure patterns than those in conventional parlors. Organic dairy systems may have different environmental pathogen dynamics related to bedding choices and treatment restrictions. Production pressure within any breed increases the challenge of maintaining immune function and udder health.

Genetic selection offers opportunities for improving environmental mastitis resistance within and across breeds. Somatic cell score is moderately heritable and responds to selection, providing indirect selection for mastitis resistance. Clinical mastitis resistance is directly evaluated in breeding programs in some countries. Udder conformation traits including udder depth, udder attachment, and teat placement affect both environmental exposure and milking characteristics. Genetic variation in immune response traits including cytokine production, neutrophil function, and pathogen recognition correlates with mastitis resistance. Genomic selection accelerates genetic progress by identifying favorable alleles in young animals. Balanced selection incorporating health along with production traits supports long-term herd improvement.

Commonly co-occurring conditions with environmental mastitis reflect shared risk factors and metabolic relationships. Transition cow metabolic disorders including hypocalcemia, ketosis, and fatty liver frequently accompany or predispose to mastitis through immune suppression. Metritis and retained placenta share the periparturient period vulnerability and immune compromise. Displaced abomasum often follows the metabolic challenges and reduced feed intake associated with severe mastitis. Laminitis may develop as a sequela to the endotoxemia of severe coliform mastitis. These conditions are interrelated through common pathophysiology, and prevention programs should address multiple risk factors simultaneously.

Conditions with similar symptoms requiring differentiation from environmental mastitis include other mammary infections and systemic diseases. Contagious mastitis pathogens cause similar clinical presentations but have different epidemiologic implications. Summer mastitis presents distinctively with its characteristic organisms and severe suppurative nature. Udder edema causes swelling that may be confused with mastitis but lacks the heat, pain, and milk changes of infection. Teat injuries and lesions may accompany or predispose to mastitis. Systemic diseases causing fever, depression, and anorexia require careful udder examination to rule out mastitis as the primary cause. Accurate diagnosis through clinical examination and culture directs appropriate treatment.

Complications and sequelae of environmental mastitis include both local and systemic effects. Quarter damage from severe inflammation may cause permanent production loss even when infection is cured. Gangrenous mastitis with tissue death occasionally develops, particularly with certain coliform or staphylococcal strains. Chronic subclinical mastitis may persist following clinical resolution, particularly with Streptococcus uberis. Systemic complications of severe coliform mastitis include disseminated intravascular coagulation, multiple organ dysfunction, and death. Recovered cows may show persistent metabolic effects and increased susceptibility to other diseases. Long-term consequences include shortened productive life and increased culling risk.